Contrast-induced acute kidney injury in patients undergoing cardiac resynchronization therapy - Incidence and prognostic importance. Sub-analysis of data from randomized TRUST CRT trial

Journal of Interventional Cardiac Electrophysiology

Volumn 40, Issue 1, 2014, Pages 1-8

  Kowalczyk, Jacek ^a   Lenarczyk, Radoslaw ^a   Kowalski, Oskar ^a   Podolecki, Tomasz ^a   Francuz, Pawel ^a   Pruszkowska Skrzep, Patrycja ^a   Szulik, Mariola ^a   Mazurek, Michal ^a   Jedrzejczyk Patej, Ewa ^a   Sredniawa, Beata ^a   Kalarus, Zbigniew ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Cardiac resynchronization therapy; Chronic kidney disease; Contrast induced acute kidney injury; Heart failure; Renal function

Indexed keywords

CREATININE; CONTRAST MEDIUM;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL PRACTICE; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HOSPITALIZATION; HUMAN; INCIDENCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; VERY ELDERLY; ACUTE KIDNEY INJURY; BLOOD; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CHEMICALLY INDUCED; CONTROLLED STUDY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; PROGNOSIS; PROSTHESIS IMPLANTATION;

ACUTE KIDNEY INJURY; ADULT; AGED; AGED, 80 AND OVER; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; CONTRAST MEDIA; CREATININE; DEFIBRILLATORS, IMPLANTABLE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; PROSTHESIS IMPLANTATION;

EID: 84895854710     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-014-9887-x     Document Type: Article

References (28)

1. Brignole, M., Auricchio, A., Baron-Esquivias, G., Bordachar, P., Boriani, G., Breithardt, O.A. et al. (2013). 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Addenda. European Heart Journal.
2. Vardas, P. E., Auricchio, A., Blanc, J. J., Daubert, J. C., Drexler, H., Ector, H., et al. (2007). Guidelines for cardiac pacing and cardiac resynchronization therapy: the Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. European Heart Journal, 28, 2256-2295. (Pubitemid 47428944)
3. Thomsen, H. S., & Morcos, S. K. (2003). Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. British Journal of Radiology, 76, 513-518. (Pubitemid 37028403)
4. Kowalczyk, J., Lenarczyk, R., Kowalski, O., Sredniawa, B., Musialik-Lydka, A., Gasior, M., et al. (2007). Different types of renal dysfunction in patients with acute myocardial infarction treated with percutaneous coronary intervention. Journal of Interventional Cardiology, 20, 143-152. (Pubitemid 46457446)
5. KDIGO AKI Work Group. (2012). KDIGO clinical practice guideline for acute kidney injury. Kidney International. Supplement, 2, 1-138.
6. Lameire, N., Kellum, J. A., & for the KDIGO AKI Guideline Work Group. (2013). Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary (Part 2). Critical Care, 17, 205.
7. Mehran, R., Aymong, E. D., Nikolsky, E., Lasic, Z., Iakovou, I., Fahy, M., et al. (2004). A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. Journal of the American College of Cardiology, 44, 1393-1399. (Pubitemid 39303939)
8. Cowburn, P. J., Patel, H., Pipes, R. R., & Parker, J. D. (2005). Contrast nephropathy post cardiac resynchronization therapy: an under-recognized complication with important morbidity. European Journal of Heart Failure, 7, 899-903. (Pubitemid 41125914)
9. Tester, G. A., Noheria, A., Carrico, H. L., Mears, J. A., Cha, Y. M., Powell, B. D., et al. (2012). Impact of radiocontrast use during left ventricular pacemaker lead implantation for cardiac resynchronization therapy. Europace, 14, 243-248.
10. Lenarczyk, R., Kowalski, O., Średniawa, B., Pruszkowska-Skrzep, P., Pluta, S., Sokal, A., et al. (2009). Triple-Site Versus Standard Cardiac Resynchronization Therapy Study (TRUST CRT): clinical rationale, design and implementation. Journal of Cardiovascular Electrophysiology, 20, 658-662.
11. Lenarczyk, R., Kowalski, O., Sredniawa, B., Pruszkowska-Skrzep, P., Mazurek, M., Jȩdrzejczyk-Patej, E., et al. (2012). Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing Triple-Site Cardiac Resynchronization Therapy: a substudy of TRUST CRT Randomized Trial. Journal of Cardiovascular Electrophysiology, 23, 1228-1236.
12. National Kidney Foundation. (2002). K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. American Journal of Kidney Diseases, 39, S1-S237.
13. McCullough, P. A., Adam, A., Becker, C. R., Davidson, C., Lameire, N., Stacul, F., et al. (2006). Epidemiology and prognostic implications of contrast-induced nephropathy. American Journal of Cardiology, 98, 5K-13K.
14. Marenzi, G., Lauri, G., Assanelli, E., Campodonico, J., De Metrio, M., Marana, I., et al. (2004). Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. Journal of the American College of Cardiology, 44, 1780-1785. (Pubitemid 39424075)
15. McCullough, P. A., Adam, A., Becker, C. R., Davidson, C., Lameire, N., Stacul, F., et al. (2006). Risk prediction of contrast-induced nephropathy. American Journal of Cardiology, 98, 27K-36K.
16. Lin, G., Gersh, B. J., Greene, E. L., Redfield, M. M., Hayes, D. L., & Brady, P. A. (2011). Renal function and mortality following cardiac resynchronization therapy. European Heart Journal, 32, 184-190.
17. Kreuz, J., Horlbeck, F., Linhart, M., Mellert, F., Fimmers, R., Schrickel, J., et al. (2012). Independent predictors of mortality in patients with advanced heart failure treated by cardiac resynchronization therapy. Europace, 14, 1596-1601.
18. Verbrugge, F. H., Dupont, M., Rivero-Ayerza, M., de Vusser, P., Van Herendael, H., Vercammen, J., et al. (2012). Comorbidity significantly affects clinical outcome after cardiac resynchronization therapy regardless of ventricular remodeling. Journal of Cardiac Failure, 18, 845-853.
19. Hosoda, J., Ishikawa, T., Matsushita, K., Matsumoto, K., Kimura, Y., Miyamoto, M., et al. (2012). Impact of renal insufficiency on long-term clinical outcome in patients with heart failure treated by cardiac resynchronization therapy. Journal of Cardiology, 60, 301-305.
20. Van Bommel, R. J., Mollema, S. A., Borleffs, C. J., Bertini, M., Ypenburg, C., Marsan, N. A., et al. (2011). Impaired renal function is associated with echocardiographic nonresponse and poor prognosis after cardiac resynchronization therapy. Journal of the American College of Cardiology, 57, 549-555.
21. Mathew, J., Katz, R., St John Sutton, M., Dixit, S., Gerstenfeld, E. P., Ghio, S., et al. (2012). Chronic kidney disease and cardiac remodelling in patients with mild heart failure: results from the REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE) study. European Journal of Heart Failure, 14, 1420-1428.
22. Cleland, J. G., Abraham, W. T., Linde, C., Gold, M. R., Young, J. B., Claude Daubert, J., et al. (2013). An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity andmortality in patients with symptomatic heart failure. European Heart Journal, 34, 3547-3556.
23. Bilchick, K. C., Kamath, S., DiMarco, J. P., & Stukenborg, G. J. (2010). Bundle-branch block morphology and other predictors of outcome after cardiac resynchronization therapy in Medicare patients. Circulation, 122, 2022-2030.
24. Onishi, T., Onishi, T., Marek, J. J., Ahmed, M., Haberman, S. C., Oyenuga, O., et al. (2013). Mechanistic features associated with improvement in mitral regurgitation after cardiac resynchronization therapy and their relation to long-term patient outcome. Circulation. Heart Failure, 6, 685-693.
25. Di Biase, L., Auricchio, A., Mohanty, P., Bai, R., Kautzner, J., Pieragnoli, P., et al. (2011). Impact of cardiac resynchronization therapy on the severity of mitral regurgitation. Europace, 13, 829-838.
26. Cabrera-Bueno, F., Molina-Mora, M. J., Alzueta, J., Pena-Hernandez, J., Jimenez-Navarro, M., Fernandez-Pastor, J., et al. (2010). Persistence of secondary mitral regurgitation and response to cardiac resynchronization therapy. European Journal of Echocardiography, 11, 131-137.
27. Richardson, M., Freemantle, N., Calvert, M. J., Cleland, J. G., Tavazzi, L., & CARE-HF Study Steering Committee and Investigators. (2007). Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined analysis from the CARE-HF trial. European Heart Journal, 28, 1827-1834. (Pubitemid 47236653)
28. Jaussaud, J., Blanc, P., Derval, N., Bordachar, P., Courregelongue, M., Roudaut, R., et al. (2010). Ventilatory response and peak circulatory power: new functional markers of response after cardiac resynchronization therapy. Archives of Cardiovascular Diseases, 103, 184-191.